Lassa Fever Research and Development (R&D) Roadmap - DRAFT FOR PUBLIC COMMENT
1 May 2018
| Technical document

Overview
Roadmap purpose: to provide a framework for identifying the vision, underpinning strategic goals, and 3 prioritizing areas and activities (from basic research to advanced development, licensure, manufacture, 4 and deployment) for accelerating the collaborative development of medical countermeasures (MCMs)—5 diagnostics, therapeutics, and vaccines—against Lassa fever.
WHO Team
R&D Blue Print (RDB)